M. Haria, HM. Bryson, Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections., in Drugs, vol. 49, n. 1, gennaio 1995, pp. 103-20, PMID7705210.
A. Polak-Wyss, H. Lengsfeld; G. Oesterhelt, Effect of oxiconazole and Ro 14-4767/002 on sterol pattern in Candida albicans., in Sabouraudia, vol. 23, n. 6, dicembre 1985, pp. 433-41, PMID3913013.
A. Polak, Preclinical data and mode of action of amorolfine., in Dermatology, 184 Suppl 1, 1992, pp. 3-7, PMID1550968.
J. Müller, A. Polak; R. Jaeger, The effect of the morpholine derivate amorolfin (Roche 14-4767/002) on the ultrastructure of Candida albicans., in Mykosen, vol. 30, n. 11, novembre 1987, pp. 528-40, PMID3328047.
A. Polak, Kinetics of amorolfine in human nails., in Mycoses, vol. 36, n. 3-4, Mar-Apr 1993, pp. 101-3, PMID8366874.
TJ. Franz, Absorption of amorolfine through human nail., in Dermatology, 184 Suppl 1, 1992, pp. 18-20, PMID1550966.
H. Mensing, A. Polak-Wyss; V. Splanemann, Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations., in Clin Exp Dermatol, 17 Suppl 1, settembre 1992, pp. 29-32, PMID1458661.
A. del Palacio-Hernanz, S. López-Gómez; P. Moreno-Palancar; F. González-Lastra, A clinical double-blind trial comparing amorolfine cream 0.5% (RO-14-4767) with bifonazole cream 1% in the treatment of dermatomycoses., in Clin Exp Dermatol, vol. 14, n. 2, marzo 1989, pp. 141-4, PMID2689018.
S. Nolting, G. Semig; HK. Friedrich; M. Dietz; R. Reckers-Czaschka; M. Bergstraesser; M. Zaug, Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses., in Clin Exp Dermatol, 17 Suppl 1, settembre 1992, pp. 56-60, PMID1458667.
A. del Palacio, F. Sanz; M. Garcia-Bravo; C. Gimeno; S. Cuetara; P. Miranda; A. R-Noriega, Single dose treatment of vaginal candidosis: randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis., in Mycoses, vol. 34, n. 1-2, pp. 85-91, PMID1922194.
D. Reinel, Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use., in Dermatology, 184 Suppl 1, 1992, pp. 21-4, PMID1532336.
Amorolfine--putting a gloss on infected nails., in Drug Ther Bull, vol. 30, n. 5, marzo 1992, p. 19, PMID1591990.
DW. Denning, EG. Evans; CC. Kibbler; MD. Richardson; MM. Roberts; TR. Rogers; DW. Warnock; RE. Warren, Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)., in BMJ, vol. 311, n. 7015, novembre 1995, pp. 1277-81, PMID7496239.
K. Kramer, E. Paul, Contact dermatitis from amorolfine-containing cream and nail lacquer., in Contact Dermatitis, vol. 34, n. 2, febbraio 1996, p. 145, PMID8681549.
K. Kaneko, N. Aoki; M. Hata; J. Yajima; S. Kawana; S. Hattori, Allergic contact dermatitis from amorolfine cream., in Contact Dermatitis, vol. 37, n. 6, dicembre 1997, p. 307, PMID9455644.
A. Fidalgo, L. Lobo, Allergic contact dermatitis due to amorolfine nail lacquer., in Dermatitis, vol. 15, n. 1, marzo 2004, p. 54, PMID15573651.
D. Rigopoulos, A. Katsambas; C. Antoniou; E. Christofidou; E. Balaskas; J. Stratigos, Discoloration of the nail plate due to the misuse of amorolfine 5% nail lacquer., in Acta Derm Venereol, vol. 76, n. 1, gennaio 1996, pp. 83-4, PMID8721508.